Investors

News Releases

Date Title  
Toggle Summary Tribute Pharmaceuticals Announces First Quarter 2015 Results
Revenue Up 60%, EBITDA Up 116% Over Comparative Period MILTON, ONTARIO -- (Marketwired) -- 05/12/15 -- Tribute Pharmaceuticals Canada Inc. (TSX VENTURE:TRX)(OTCQX:TBUFF) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development
Toggle Summary Tribute Pharmaceuticals Announces Second Quarter 2015 Results
Revenue Up 59%, Gross Profit Up 101% over Comparative Period MILTON, ONTARIO -- (Marketwired) -- 08/17/15 -- Tribute Pharmaceuticals Canada Inc. (TSX VENTURE:TRX)(OTCQX:TBUFF) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing,
Toggle Summary Tribute Pharmaceuticals Announces Strong 2014 Fourth Quarter and Year End Results
4th Quarter Revenue Up 70.5% and EBITDA Up 217% Over Comparative Periods MILTON, ONTARIO -- (Marketwired) -- 03/03/15 -- Tribute Pharmaceuticals Canada Inc. (TSX VENTURE:TRX)(OTCQX:TBUFF) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition,
Toggle Summary Tribute Pharmaceuticals Board Members and Management Exercise Series A Warrants
MILTON, ONTARIO -- (Marketwired) -- 03/02/15 -- Tribute Pharmaceuticals Canada Inc. (OTCQX:TBUFF) (TSX VENTURE:TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the
Toggle Summary Tribute Pharmaceuticals Engages BND Projects Inc. as Investor Relations Service Provider and Grants Options to Certain Officers and Directors
MILTON, ONTARIO -- (Marketwired) -- 01/29/15 -- Tribute Pharmaceuticals Canada Inc. (OTCQB:TBUFF)(TSX VENTURE:TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the
Toggle Summary Tribute Pharmaceuticals Provides Update of 2014 Revenues; Anticipates Fourth Quarter Revenue Growth in Excess of 60% and Full Year Revenue Growth of Greater Than 20%
MILTON, ONTARIO -- (Marketwired) -- 01/27/15 -- Tribute Pharmaceuticals Canada Inc. (OTCQX:TBUFF)(TSX VENTURE:TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the
Toggle Summary Tribute Pharmaceuticals Schedules First Quarter 2015 Financial Results Conference Call
MILTON, ONTARIO -- (Marketwired) -- 05/08/15 -- Tribute Pharmaceuticals Canada Inc. (OTCQX:TBUFF)(TSX VENTURE:TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the
Toggle Summary Tribute Pharmaceuticals Schedules Fourth Quarter and 2014 Year End Financial Results Conference Call
MILTON, ONTARIO -- (Marketwired) -- 02/26/15 -- Tribute Pharmaceuticals Canada Inc. (OTCQX:TBUFF)(TSX VENTURE:TRX) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the
Toggle Summary Tribute Pharmaceuticals to Participate at Laurentian Bank Securities Annual Investor Conference
MILTON, ONTARIO -- (Marketwired) -- 04/02/15 -- Tribute Pharmaceuticals Canada Inc. ("Tribute" or the "Company") (TSX VENTURE:TRX) (OTCQX:TBUFF), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the
Toggle Summary Tribute Pharmaceuticals to Present at the Bloom Burton & Co. Annual Healthcare Investor Conference
MILTON, ONTARIO -- (Marketwired) -- 04/27/15 -- Tribute Pharmaceuticals Canada Inc. (TSX VENTURE:TRX)(OTCQX:TBUFF) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the

Copyright West LLC. Minimum 15 minutes delayed.